Application | Comment | Organism |
---|---|---|
pharmacology | enzyme is a target for development of antibiotics | Haemophilus influenzae |
Crystallization (Comment) | Organism |
---|---|
15 mg/ml purified recombinant enzyme, in 10 mM HEPES, pH 7.0, 1 mM EDTA, 1 mM DTT, crystallized as apoenzyme, as hemithioacetal, or as hemithioacetal structure with bound phosphate, hanging drop vapour diffusion method, 20°C, 1:1 mixture of protein solution and precipitant solution, the latter containing 24-28% PEG 3350, 0.2 M ammonium acetate, 0.1 M Tris, pH 8.5, overnight, substrate complexing by soaking of crystals in mother liquor with 50 mM potassium phosphate, crystals are frozen in precipitant solution with 20% glycerol added, X-ray diffraction structure determination and analysis at 2.0-2.15 A resolution, modeling | Haemophilus influenzae |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
S-methyl cysteine sulfoxide | inhibitor binding structure deduced from crystal structure | Haemophilus influenzae |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Haemophilus influenzae | P44801 | - |
- |
no activity in Homo sapiens | - |
- |
- |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
L-aspartate 4-semialdehyde + phosphate + NADP+ = L-4-aspartyl phosphate + NADPH + H+ | catalytic mechanism, identification and structural characterization of the tetrahedral reaction intermediate, substrate binding structure | Haemophilus influenzae |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-aspartate-4-semialdehyde + phosphate + NADP+ | - |
Haemophilus influenzae | L-4-aspartyl phosphate + NADPH | - |
? |
Synonyms | Comment | Organism |
---|---|---|
ASADH | - |
Haemophilus influenzae |
L-aspartate-beta-semialdehyde dehydrogenase | - |
Haemophilus influenzae |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADP+ | dependent on | Haemophilus influenzae |